JP2002524092A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524092A5
JP2002524092A5 JP2000569230A JP2000569230A JP2002524092A5 JP 2002524092 A5 JP2002524092 A5 JP 2002524092A5 JP 2000569230 A JP2000569230 A JP 2000569230A JP 2000569230 A JP2000569230 A JP 2000569230A JP 2002524092 A5 JP2002524092 A5 JP 2002524092A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000569230A
Other languages
Japanese (ja)
Other versions
JP3732408B2 (ja
JP2002524092A (ja
Filing date
Publication date
Priority claimed from US09/148,712 external-priority patent/US6441140B1/en
Application filed filed Critical
Publication of JP2002524092A publication Critical patent/JP2002524092A/ja
Publication of JP2002524092A5 publication Critical patent/JP2002524092A5/ja
Application granted granted Critical
Publication of JP3732408B2 publication Critical patent/JP3732408B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000569230A 1998-09-04 1999-08-26 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生 Expired - Lifetime JP3732408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/148,712 US6441140B1 (en) 1998-09-04 1998-09-04 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US09/148,712 1998-09-04
PCT/US1999/019597 WO2000014536A1 (en) 1998-09-04 1999-08-26 Production of motif-specific and context-independent antibodies using peptide libraries as antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005260207A Division JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Publications (3)

Publication Number Publication Date
JP2002524092A JP2002524092A (ja) 2002-08-06
JP2002524092A5 true JP2002524092A5 (enExample) 2005-12-22
JP3732408B2 JP3732408B2 (ja) 2006-01-05

Family

ID=22527002

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000569230A Expired - Lifetime JP3732408B2 (ja) 1998-09-04 1999-08-26 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2005260207A Expired - Lifetime JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2012058996A Expired - Lifetime JP5648007B2 (ja) 1998-09-04 2012-03-15 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2014036821A Withdrawn JP2014132019A (ja) 1998-09-04 2014-02-27 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2016113229A Pending JP2016210783A (ja) 1998-09-04 2016-06-07 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2005260207A Expired - Lifetime JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2012058996A Expired - Lifetime JP5648007B2 (ja) 1998-09-04 2012-03-15 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2014036821A Withdrawn JP2014132019A (ja) 1998-09-04 2014-02-27 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2016113229A Pending JP2016210783A (ja) 1998-09-04 2016-06-07 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Country Status (6)

Country Link
US (5) US6441140B1 (enExample)
EP (3) EP2325204B1 (enExample)
JP (5) JP3732408B2 (enExample)
CA (1) CA2341143C (enExample)
DE (1) DE69936389T2 (enExample)
WO (1) WO2000014536A1 (enExample)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884597B1 (en) * 1998-01-20 2005-04-26 Medical & Biological Laboratories, Co., Ltd. Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes
US7198896B2 (en) * 1998-09-04 2007-04-03 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US20120244594A9 (en) * 1998-09-04 2012-09-27 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US7300753B2 (en) * 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US6441140B1 (en) * 1998-09-04 2002-08-27 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US9085609B2 (en) * 1998-09-04 2015-07-21 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US7208581B1 (en) 1999-11-05 2007-04-24 The Burnham Institute TRAF family proteins
AU2625201A (en) * 2000-01-03 2001-07-16 Ramot University Authority For Applied Research And Industrial Development Ltd. Glycogen synthase kinase-3 inhibitors
WO2001083518A2 (en) * 2000-05-04 2001-11-08 Mount Sinai Hospital Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
US20020102248A1 (en) * 2000-09-06 2002-08-01 The Government Of The United States Of America Modulating response to genotoxic stress
EP1304561A4 (en) * 2001-03-23 2006-01-11 Japan Science & Tech Agency PROBE FOR PROBING THE PHOSPHORYLATION / DEPHOSPHORYLATION OF PROTEIN AND METHOD FOR DETECTING AND QUANTIFYING THE PHOSPHORYLATION / DEPHOSPHORYLATION OF PROTEIN
EP3467122A1 (en) 2001-06-21 2019-04-10 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US20110111424A1 (en) 2001-06-21 2011-05-12 Cell Signaling Technology, Inc. Analysis of ubiquitinated polypeptides
US7378432B2 (en) * 2001-09-14 2008-05-27 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
US7166441B2 (en) * 2002-03-12 2007-01-23 Perseptive Biosystems Inc. Method and apparatus for the identification and quantification of biomolecules
GB0208104D0 (en) * 2002-04-09 2002-05-22 Univ Dundee Method
EP1569956B1 (en) 2002-12-12 2014-02-26 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
CA2530111A1 (en) * 2003-06-27 2005-01-06 Tel-Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
US20050131219A1 (en) * 2003-08-18 2005-06-16 Urdea Michael S. Methods for reducing complexity of a sample using small epitope antibodies
WO2005019828A1 (en) * 2003-08-20 2005-03-03 Amorfix Life Sciences Ltd. Epitope protection assay and method for detecting protein conformations
US20050064507A1 (en) * 2003-09-11 2005-03-24 James Stephen Shaw Determining kinase specificity
US7282339B2 (en) * 2003-09-17 2007-10-16 Invitrogen Corporation Competitive immunoassay
US20050244905A1 (en) * 2004-04-29 2005-11-03 Harry Ischiropoulos Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
US8852879B2 (en) 2004-04-29 2014-10-07 The Children's Hospital Of Philadelphia Materials and methods for the detection of nitrated fibrinogen
US7973134B2 (en) * 2004-07-07 2011-07-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
US20070048797A1 (en) * 2004-08-11 2007-03-01 Xing Su Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules
US7935790B2 (en) * 2004-10-04 2011-05-03 Cell Singaling Technology, Inc. Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
US20070224662A1 (en) * 2004-12-17 2007-09-27 Jun Luo Post-translational modification of proteins in cell-free expression systems
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
US8062887B2 (en) * 2005-04-01 2011-11-22 National University Corporation, Hokkaido University Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
US20090099340A1 (en) * 2007-10-12 2009-04-16 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
WO2006117007A1 (en) * 2005-05-03 2006-11-09 The Antibody Project Aps Methods for obtaining antigen specific antibodies
WO2007002483A1 (en) * 2005-06-24 2007-01-04 Beckman Coulter, Inc. Immunoassay of phosphorylated proteins
US7906297B2 (en) 2005-07-20 2011-03-15 Cell Signaling Technology, Inc. Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof
US20100151495A9 (en) * 2005-08-31 2010-06-17 Cell Signaling Technolgy, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
EP1934867A2 (en) * 2005-08-31 2008-06-25 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
US8859209B2 (en) 2006-01-12 2014-10-14 Carviar Aps Reimmunization and antibody design
WO2008076139A1 (en) * 2006-03-10 2008-06-26 Tethys Bioscience, Inc. Multiplex protein fractionation
US20090298093A1 (en) * 2006-04-27 2009-12-03 Roberto Polakiewicz Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
EP2463306A1 (en) * 2006-05-02 2012-06-13 Carviar ApS Method for immunizing an avian species
US20090325312A1 (en) * 2006-05-12 2009-12-31 Ailan Guo Reagens for the detection of protein acetylation signaling pathways
US20150232540A1 (en) * 2006-07-11 2015-08-20 Cell Signaling Technology, Inc. Analysis of ubiquitnated polypeptides
US7939636B2 (en) * 2006-08-11 2011-05-10 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US20100092992A1 (en) * 2006-08-17 2010-04-15 Peter Hornbeck Lysine acetylation sites
US20090258442A1 (en) * 2006-08-31 2009-10-15 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
EP1975184A3 (en) * 2007-03-26 2008-11-26 Cell Signaling Technology, Inc. Serine or threonine phosphorylation sites
US20080238709A1 (en) * 2007-03-28 2008-10-02 Faramarz Vaziri One-way communication apparatus with dynamic key generation
US7977462B2 (en) 2007-04-19 2011-07-12 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
WO2009058908A2 (en) 2007-10-29 2009-05-07 Eisai R & D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
US20090220991A1 (en) * 2008-02-29 2009-09-03 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
EP2304439A4 (en) * 2008-05-29 2012-07-04 Nuclea Biotechnologies Llc ANTI-phospho-AKT ANTIBODY
US9868781B2 (en) * 2008-06-02 2018-01-16 Cornell University Antibodies for ubiquitinated proteins
US7933146B2 (en) * 2008-10-08 2011-04-26 Seagate Technology Llc Electronic devices utilizing spin torque transfer to flip magnetic orientation
US20110212119A1 (en) * 2008-10-31 2011-09-01 Proteonova, Inc. Methods for making hiv vaccines and related compositions
US8771693B2 (en) * 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
US9453845B2 (en) 2010-02-01 2016-09-27 Cell Signaling Technology, Inc. Mass spectroscopy analysis of mutant polypeptides in biological samples
AU2011235833A1 (en) * 2010-04-02 2012-10-25 Kalobios Pharmaceuticals, Inc. Generation of antibodies to an epitope of interest
FI20105715A0 (fi) * 2010-06-18 2010-06-18 Helsingin Yliopisto Asetyloituun HMGB1:een sitoutuva polyklonaalinen vasta-aine
WO2012061732A1 (en) 2010-11-05 2012-05-10 Cell Signaling Technology, Inc. Motif-specific and context-independent antibodies to a cleaved caspase motif or a sumoylated lysine-containing motif
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
CN104039350B (zh) * 2011-09-17 2019-07-05 源道隆(苏州)医学科技有限公司 任意三个或以上氨基酸残基构成的多肽表位及其相关抗体的诱导
EP2573565A1 (en) 2011-09-23 2013-03-27 Gerhard Matthias Kresbach Immune detection method for common epitopes of two or more analytes in samples of complex compositions, device, and kit for enabling said immune detection method
WO2013125221A1 (ja) * 2012-02-21 2013-08-29 静岡県 抗体精製用アフィニティリガンド
JP6293409B2 (ja) * 2012-10-04 2018-03-14 国立大学法人富山大学 抗原特異的ウサギ抗体産生細胞の迅速な特定方法およびその利用
US9688747B2 (en) 2013-03-15 2017-06-27 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2015155738A2 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
WO2015157530A2 (en) * 2014-04-09 2015-10-15 Brandeis University Enzymatically responsive magnetic particles and their use
US10822604B2 (en) 2014-05-02 2020-11-03 Morphosys Ag Peptide libraries
CA3005070A1 (en) 2015-11-11 2017-05-18 Serimmune Inc. Methods and compositions for assessing antibody specificities
CA3071894A1 (en) * 2017-08-04 2019-02-07 Abcam Plc Methods and compositions for the development of antibodies specific to epitope post-translational modification status
US20230073946A1 (en) * 2020-01-20 2023-03-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Affinity peptide conjugated with antioxidant for protection of proteins from oxidation
GB202012722D0 (en) * 2020-08-14 2020-09-30 Abcam Plc Validation method
WO2022120523A1 (en) * 2020-12-07 2022-06-16 Nucmito Pharmaceuticals Co. Ltd. RXRα BINDERS AND RXRα/PLK1 MODULATORS
CN116444677A (zh) * 2023-06-09 2023-07-18 中国人民解放军军事科学院军事医学研究院 一种FoxM1蛋白Y575磷酸化的多克隆抗体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227596A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd 抗リン酸化チロシンモノクロ−ナル抗体およびそれを産生するハイブリド−マ
EP0544942A1 (en) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel tools for the diagnosis and treatment of Alzheimer disease
JPH05244987A (ja) * 1992-02-28 1993-09-24 Unitika Ltd 抗硫酸化チロシン抗体,その製造方法及び抗硫酸化チロシンモノクローナル抗体を産生するハイブリドーマ
US5532167A (en) * 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
CA2172771A1 (en) * 1995-03-28 1996-09-29 Akiyoshi Tani Method for assaying map kinase
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
FR2757864B1 (fr) 1996-12-30 1999-03-19 Centre Nat Rech Scient Anticorps reconnaissant specifiquement une proteine nitrosylee, leur procede de preparation, leur utilisation therapeutique et diagnostique
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
US6441140B1 (en) 1998-09-04 2002-08-27 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US9919577B2 (en) 2014-11-14 2018-03-20 Hyundai Motor Company Air-conditioning device for vehicle

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
BE2010C011I2 (enExample)
BRPI0017527B8 (enExample)
BE2008C047I2 (enExample)
BE2011C004I2 (enExample)
BRPI0001672A2 (enExample)
BRPI0001542A2 (enExample)
BRPI0012675B8 (enExample)
BRPI0017522A2 (enExample)
BRPI0303609A (enExample)
BRMU7902607U2 (enExample)
BRPI9917761A2 (enExample)
AU2000268132A8 (enExample)
CN3097870S (enExample)